Abstract OBJECTIVE: Autologous peripheral blood stem cell transplantation (APBSCT) is an important method for treatment of malignant solid tumors in children. The mobilization and collection of blood stem cells is crucial for APBSCT. This study aimed to evaluate the clinical efficacy of mobilization and collection of blood stem cells by CIE or IEV chemotherapy protocol in APBSCT in children with neuroblastoma (NB) or rhabdomyosarcoma. METHODS: The protocols of CIE (cisplatin, etoposide) and IEV (vincristine, dosfamide, etoposide) were used as mobilization chemotherapy in 8 cases of NB with stage IV and 3 cases of rhabdomysacoma with stage III, respectively. The results of the mobilization of blood stem cells were observed. RESULTS: Of the 11 cases, mononuclear cells (MNC) and CD34+ cells were successfully collected and the volume of MNC and CD34 averaged (5.55±1.43)×108/kg and (4.88±2.48)×106/kg, respectively. No severe complications were observed during the mobilization and collection. A rapid hemopoietic reconstitution was observed in 10 children after APBSCT. One with NB out of the 10 children died of left heart failure 32 days after APBSCT. Others (9 cases) showed a nearly normal result of routine peripheral blood test 60 days after APBSCT. CONCLUSIONS: CIE or IEV protocol is effective and safe for the mobilization and collection of peripheral blood stem cells in children with NB or rhabdomysacoma.
ZHANG Yi,ZHANG Wei-Ling,HUANG Dong-Sheng et al. Mobilization and collection of autologous peripheral blood stem cells by CIE or IEV protocol in children with malignant solid tumors[J]. 中国当代儿科杂志, 2011, 13(6): 471-474.
ZHANG Yi,ZHANG Wei-Ling,HUANG Dong-Sheng et al. Mobilization and collection of autologous peripheral blood stem cells by CIE or IEV protocol in children with malignant solid tumors[J]. CJCP, 2011, 13(6): 471-474.
［3］Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D′Angio G, et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma［J］. J Clin Oncol, 1988, 6(12): 1874-1881.
［6］Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA, et al. Regimen related toxicity in patients undergoing bone marrow transplantation［J］.J Clin Oncol,1988, 6(10):1562.
［7］Balduzzi A, Perseghin P, Dassi M, Bonanomi S, Rovelli A, Gaipa G, et al. Peripheral blood stem cell collection in children with acute leukemia: effectiveness of the ‘DIAVE’. mobilizing regimen［J］. Bone Marrow Transplant, 2002, 30(7): 413-416.
［8］Tang S, Huang D, Wang J, Wei X, Ran C, Peng Y, et al. Application of autologous peripheral blood stem cell transplantation in children with maligant tumor［J］. Clin Med J (Engl), 2001,114(10):1098-1101.
［9］Sevilla J, Plaza SF, González-Vicent M, Lassaletta A, Ramírez M, Madero L, et al. PBSC collection in extremely low weight infants: a single-center experience［J］. Cytotherapy, 2007, 9(4): 356-361.
［10］Cecyn KZ, Seber A, Ginani VC, Goncalves AV, Caram EM, Oguro T, et al. Large-volume leukapheresis for peripheral blood progenitor cell collection in low body weight pediatric patients: a single center experience［J］. Transfus Apher Sci, 2005, 32(3): 269-274.
［11］Sevilla J, Gonzalez-Vicent M, Madero L, García-Sánchez F, Angel Diaz M. Large volume leukapheresis in small children: safety profile and variables affecting peripheral blood progenitor cell collection［J］. Bone Marrow Transplant, 2003, 31(4): 263-267.
